Trials / Unknown
UnknownNCT06295302
A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase IIa Study to Explore the Efficacy, Safety, and Pharmacokinetic Profile of HWH486 in Adults With Chronic Spontaneous Urticaria(CSU)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Hubei Biological Medicine Industrial Technology Institute Co., Ltd. · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-bind and placebo-controlled phase IIa dose-finding study to assess the safety and efficacy of HWH486 in adults with chronic spontaneous urticaria (CSU). In addition, the pharmacokinetic characteristics will also be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HWH486 | HWH486 capsule was administrated orally |
| DRUG | Placebo | Matching placebo was administrated orally |
Timeline
- Start date
- 2023-12-13
- Primary completion
- 2025-12-01
- Completion
- 2026-01-01
- First posted
- 2024-03-06
- Last updated
- 2024-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06295302. Inclusion in this directory is not an endorsement.